Interleukin-1 Regulates Multiple Atherogenic Mechanisms in Response to Fat Feeding
Open Access
- 6 April 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (4) , e5073
- https://doi.org/10.1371/journal.pone.0005073
Abstract
Atherosclerosis is an inflammatory process that develops in individuals with known risk factors that include hypertension and hyperlipidaemia, influenced by diet. However, the interplay between diet, inflammatory mechanisms and vascular risk factors requires further research. We hypothesised that interleukin-1 (IL-1) signaling in the vessel wall would raise arterial blood pressure and promote atheroma. Apoe−/− and Apoe−/−/IL-1R1−/− mice were fed high fat diets for 8 weeks, and their blood pressure and atherosclerosis development measured. Apoe−/−/IL-R1−/− mice had a reduced blood pressure and significantly less atheroma than Apoe−/− mice. Selective loss of IL-1 signaling in the vessel wall by bone marrow transplantation also reduced plaque burden (p<0.05). This was associated with an IL-1 mediated loss of endothelium-dependent relaxation and an increase in vessel wall Nox 4. Inhibition of IL-1 restored endothelium-dependent vasodilatation and reduced levels of arterial oxidative stress. The IL-1 cytokine system links atherogenic environmental stimuli with arterial inflammation, oxidative stress, increased blood pressure and atherosclerosis. This is the first demonstration that inhibition of a single cytokine can block the rise in blood pressure in response to an environmental stimulus. IL-1 inhibition may have profound beneficial effects on atherogenesis in man.Keywords
This publication has 40 references indexed in Scilit:
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid ArthritisCirculation, 2008
- Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial InfarctionCirculation, 2008
- The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCε inhibitionProceedings of the National Academy of Sciences, 2006
- Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery modelCardiovascular Research, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Lack of Interleukin-1 Receptor Antagonist Modulates Plaque Composition in Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Interleukin-1 and Nitric Oxide Increase NADPH Oxidase Activity in Human Coronary Artery Smooth Muscle CellsMedical Principles and Practice, 2003
- Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- The type II ‘decoy’ receptor: A novel regulatory pathway for interleukin 1Immunology Today, 1994